TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Bio-Therapeutic Glycoproteins Market, Global Outlook and Forecast 2023-2029

Bio-Therapeutic Glycoproteins Market, Global Outlook and Forecast 2023-2029

  • Category:Life Sciences
  • Published on : 06 June 2023
  • Pages :75
  • Formats:
  • Report Code:SMR-7704747
OfferClick for best price

Best Price: $2600

BioTherapeutic Glycoproteins Market Size, Share 2023


Bio-Therapeutic Glycoproteins are bioactive compounds with carbohydrates attached to proteins. Glycan is the specific site where carbohydrate attaches to proteins and process of production is called glycosylation. Bio-therapeutic glycoproteins produced with glycan moieties that are similar to natural mammal glycans. The most common types are glycosylation O-linked and N-linked that are mainly depends on protein sequence attachment. Carbohydrates linked to proteins through either ? and ? linkages. Glycosylation is an important process of bio-therapeutic glycoproteins because it is critically modulated into bioactivity, stability, solubility against proteolysis, yield, clearance rate from circulation and immunogenicity. The bio-therapeutic glycoproteins mainly produced by yeast expression systems, insect cells, mammalian systems, and plant-based expression systems. In yeast expression systems, yeast is cultured chemically to scale up fermentation to an industrial level. Yeast and human share same N-glycan's linkage. Insect cells represent an alternative system for expression of recombinant bio-therapeutic proteins. Later recombinant proteins are separated from insect cells. Mammalian Systems are used to produce complex bio-therapeutic glycoproteins. Most of the FDA approved bio-therapeutic glycoproteins derived from mammalian systems. Plant-based expression systems used for the scale-up production of glycoproteins. Among all systems, mammalian systems are well established in pharmaceuticals. Some examples of bio-therapeutic glycoproteins include tocilizumab, bevacizumab, adalimumab, etc.

This report aims to provide a comprehensive presentation of the global market for Bio-Therapeutic Glycoproteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio-Therapeutic Glycoproteins. This report contains market size and forecasts of Bio-Therapeutic Glycoproteins in global, including the following market information:

Global Bio-Therapeutic Glycoproteins Market Revenue, 2018-2023, 2024-2029, ($ millions)

Global Bio-Therapeutic Glycoproteins Market Sales, 2018-2023, 2024-2029, (K Units)

Global top five Bio-Therapeutic Glycoproteins companies in 2022 (%)

The global Bio-Therapeutic Glycoproteins market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The potential benefits of Bio-Therapeutic Glycoproteins have been a subject of rising industrial interest in the context of wide range application. So, far they include several protein classes like antisera, cytokines, clotting factors, hormones, enzymes and enzyme inhibitors have been best suited physiologically. The trend of industrial developments likely continues alongside with growing knowledge about the functions of bio-therapeutic glycoproteins. Bio-Therapeutic Glycoproteins are a fastest growing field in the pharmaceutical industry due to a wide range of applicability. The mammalian expression system is used to produce glycoproteins that coded with human-like glycans. Bio-Therapeutic glycoproteins represent an integrated treatment for most of the autoimmune disorders, cancers, replacement therapies like hormone and enzyme substituted. All these benefits of glycoproteins drive the robust growth of the Bio-Therapeutic Glycoproteins market.

We surveyed the Bio-Therapeutic Glycoproteins manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bio-Therapeutic Glycoproteins Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global Bio-Therapeutic Glycoproteins Market Segment Percentages, by Type, 2022 (%)

Antisera

Cytokines

Clotting Factors

Hormones

Enzymes

Enzyme Inhibitors

Global Bio-Therapeutic Glycoproteins Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global Bio-Therapeutic Glycoproteins Market Segment Percentages, by Application, 2022 (%)

Oncology and Haematology

Diabetes

Cardiology

Inflammatory Diseases

Others

Global Bio-Therapeutic Glycoproteins Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global Bio-Therapeutic Glycoproteins Market Segment Percentages, By Region and Country, 2022 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bio-Therapeutic Glycoproteins revenues in global market, 2018-2023 (Estimated), ($ millions)

Key companies Bio-Therapeutic Glycoproteins revenues share in global market, 2022 (%)

Key companies Bio-Therapeutic Glycoproteins sales in global market, 2018-2023 (Estimated), (K Units)

Key companies Bio-Therapeutic Glycoproteins sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

Genentech

Hoffmann-La Roche

Genzyme Corp

Abbott Laboratories

Amgen

Biogen

Merck

GlaxoSmithKline

Novartis Pharmaceuticals Corp

Outline of Major Chapters:

Chapter 1: Introduces the definition of Bio-Therapeutic Glycoproteins, market overview.

Chapter 2: Global Bio-Therapeutic Glycoproteins market size in revenue and volume.

Chapter 3: Detailed analysis of Bio-Therapeutic Glycoproteins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Bio-Therapeutic Glycoproteins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global Bio-Therapeutic Glycoproteins capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.

Report Attributes Report Details
Report Title Bio-Therapeutic Glycoproteins Market, Global Outlook and Forecast 2023-2029
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2022
Forecast Year 2030
Number of Pages 75 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 Bio-Therapeutic Glycoproteins Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bio-Therapeutic Glycoproteins Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bio-Therapeutic Glycoproteins Overall Market Size
2.1 Global Bio-Therapeutic Glycoproteins Market Size: 2022 VS 2029
2.2 Global Bio-Therapeutic Glycoproteins Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Bio-Therapeutic Glycoproteins Sales: 2018-2029
3 Company Landscape
3.1 Top Bio-Therapeutic Glycoproteins Players in Global Market
3.2 Top Global Bio-Therapeutic Glycoproteins Companies Ranked by Revenue
3.3 Global Bio-Therapeutic Glycoproteins Revenue by Companies
3.4 Global Bio-Therapeutic Glycoproteins Sales by Companies
3.5 Global Bio-Therapeutic Glycoproteins Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Bio-Therapeutic Glycoproteins Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Bio-Therapeutic Glycoproteins Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bio-Therapeutic Glycoproteins Players in Global Market
3.8.1 List of Global Tier 1 Bio-Therapeutic Glycoproteins Companies
3.8.2 List of Global Tier 2 and Tier 3 Bio-Therapeutic Glycoproteins Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Bio-Therapeutic Glycoproteins Market Size Markets, 2022 & 2029
4.1.2 Antisera
4.1.3 Cytokines
4.1.4 Clotting Factors
4.1.5 Hormones
4.1.6 Enzymes
4.1.7 Enzyme Inhibitors
4.2 By Type - Global Bio-Therapeutic Glycoproteins Revenue & Forecasts
4.2.1 By Type - Global Bio-Therapeutic Glycoproteins Revenue, 2018-2023
4.2.2 By Type - Global Bio-Therapeutic Glycoproteins Revenue, 2024-2029
4.2.3 By Type - Global Bio-Therapeutic Glycoproteins Revenue Market Share, 2018-2029
4.3 By Type - Global Bio-Therapeutic Glycoproteins Sales & Forecasts
4.3.1 By Type - Global Bio-Therapeutic Glycoproteins Sales, 2018-2023
4.3.2 By Type - Global Bio-Therapeutic Glycoproteins Sales, 2024-2029
4.3.3 By Type - Global Bio-Therapeutic Glycoproteins Sales Market Share, 2018-2029
4.4 By Type - Global Bio-Therapeutic Glycoproteins Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Bio-Therapeutic Glycoproteins Market Size, 2022 & 2029
5.1.2 Oncology and Haematology
5.1.3 Diabetes
5.1.4 Cardiology
5.1.5 Inflammatory Diseases
5.1.6 Others
5.2 By Application - Global Bio-Therapeutic Glycoproteins Revenue & Forecasts
5.2.1 By Application - Global Bio-Therapeutic Glycoproteins Revenue, 2018-2023
5.2.2 By Application - Global Bio-Therapeutic Glycoproteins Revenue, 2024-2029
5.2.3 By Application - Global Bio-Therapeutic Glycoproteins Revenue Market Share, 2018-2029
5.3 By Application - Global Bio-Therapeutic Glycoproteins Sales & Forecasts
5.3.1 By Application - Global Bio-Therapeutic Glycoproteins Sales, 2018-2023
5.3.2 By Application - Global Bio-Therapeutic Glycoproteins Sales, 2024-2029
5.3.3 By Application - Global Bio-Therapeutic Glycoproteins Sales Market Share, 2018-2029
5.4 By Application - Global Bio-Therapeutic Glycoproteins Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Bio-Therapeutic Glycoproteins Market Size, 2022 & 2029
6.2 By Region - Global Bio-Therapeutic Glycoproteins Revenue & Forecasts
6.2.1 By Region - Global Bio-Therapeutic Glycoproteins Revenue, 2018-2023
6.2.2 By Region - Global Bio-Therapeutic Glycoproteins Revenue, 2024-2029
6.2.3 By Region - Global Bio-Therapeutic Glycoproteins Revenue Market Share, 2018-2029
6.3 By Region - Global Bio-Therapeutic Glycoproteins Sales & Forecasts
6.3.1 By Region - Global Bio-Therapeutic Glycoproteins Sales, 2018-2023
6.3.2 By Region - Global Bio-Therapeutic Glycoproteins Sales, 2024-2029
6.3.3 By Region - Global Bio-Therapeutic Glycoproteins Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Bio-Therapeutic Glycoproteins Revenue, 2018-2029
6.4.2 By Country - North America Bio-Therapeutic Glycoproteins Sales, 2018-2029
6.4.3 US Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.4.4 Canada Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.4.5 Mexico Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Bio-Therapeutic Glycoproteins Revenue, 2018-2029
6.5.2 By Country - Europe Bio-Therapeutic Glycoproteins Sales, 2018-2029
6.5.3 Germany Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.5.4 France Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.5.5 U.K. Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.5.6 Italy Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.5.7 Russia Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.5.8 Nordic Countries Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.5.9 Benelux Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Bio-Therapeutic Glycoproteins Revenue, 2018-2029
6.6.2 By Region - Asia Bio-Therapeutic Glycoproteins Sales, 2018-2029
6.6.3 China Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.6.4 Japan Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.6.5 South Korea Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.6.6 Southeast Asia Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.6.7 India Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Bio-Therapeutic Glycoproteins Revenue, 2018-2029
6.7.2 By Country - South America Bio-Therapeutic Glycoproteins Sales, 2018-2029
6.7.3 Brazil Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.7.4 Argentina Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Bio-Therapeutic Glycoproteins Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Bio-Therapeutic Glycoproteins Sales, 2018-2029
6.8.3 Turkey Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.8.4 Israel Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.8.5 Saudi Arabia Bio-Therapeutic Glycoproteins Market Size, 2018-2029
6.8.6 UAE Bio-Therapeutic Glycoproteins Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Genentech
7.1.1 Genentech Company Summary
7.1.2 Genentech Business Overview
7.1.3 Genentech Bio-Therapeutic Glycoproteins Major Product Offerings
7.1.4 Genentech Bio-Therapeutic Glycoproteins Sales and Revenue in Global (2018-2023)
7.1.5 Genentech Key News & Latest Developments
7.2 Hoffmann-La Roche
7.2.1 Hoffmann-La Roche Company Summary
7.2.2 Hoffmann-La Roche Business Overview
7.2.3 Hoffmann-La Roche Bio-Therapeutic Glycoproteins Major Product Offerings
7.2.4 Hoffmann-La Roche Bio-Therapeutic Glycoproteins Sales and Revenue in Global (2018-2023)
7.2.5 Hoffmann-La Roche Key News & Latest Developments
7.3 Genzyme Corp
7.3.1 Genzyme Corp Company Summary
7.3.2 Genzyme Corp Business Overview
7.3.3 Genzyme Corp Bio-Therapeutic Glycoproteins Major Product Offerings
7.3.4 Genzyme Corp Bio-Therapeutic Glycoproteins Sales and Revenue in Global (2018-2023)
7.3.5 Genzyme Corp Key News & Latest Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Bio-Therapeutic Glycoproteins Major Product Offerings
7.4.4 Abbott Laboratories Bio-Therapeutic Glycoproteins Sales and Revenue in Global (2018-2023)
7.4.5 Abbott Laboratories Key News & Latest Developments
7.5 Amgen
7.5.1 Amgen Company Summary
7.5.2 Amgen Business Overview
7.5.3 Amgen Bio-Therapeutic Glycoproteins Major Product Offerings
7.5.4 Amgen Bio-Therapeutic Glycoproteins Sales and Revenue in Global (2018-2023)
7.5.5 Amgen Key News & Latest Developments
7.6 Biogen
7.6.1 Biogen Company Summary
7.6.2 Biogen Business Overview
7.6.3 Biogen Bio-Therapeutic Glycoproteins Major Product Offerings
7.6.4 Biogen Bio-Therapeutic Glycoproteins Sales and Revenue in Global (2018-2023)
7.6.5 Biogen Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Bio-Therapeutic Glycoproteins Major Product Offerings
7.7.4 Merck Bio-Therapeutic Glycoproteins Sales and Revenue in Global (2018-2023)
7.7.5 Merck Key News & Latest Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Company Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Bio-Therapeutic Glycoproteins Major Product Offerings
7.8.4 GlaxoSmithKline Bio-Therapeutic Glycoproteins Sales and Revenue in Global (2018-2023)
7.8.5 GlaxoSmithKline Key News & Latest Developments
7.9 Novartis Pharmaceuticals Corp
7.9.1 Novartis Pharmaceuticals Corp Company Summary
7.9.2 Novartis Pharmaceuticals Corp Business Overview
7.9.3 Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Major Product Offerings
7.9.4 Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Sales and Revenue in Global (2018-2023)
7.9.5 Novartis Pharmaceuticals Corp Key News & Latest Developments
8 Global Bio-Therapeutic Glycoproteins Production Capacity, Analysis
8.1 Global Bio-Therapeutic Glycoproteins Production Capacity, 2018-2029
8.2 Bio-Therapeutic Glycoproteins Production Capacity of Key Manufacturers in Global Market
8.3 Global Bio-Therapeutic Glycoproteins Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Bio-Therapeutic Glycoproteins Supply Chain Analysis
10.1 Bio-Therapeutic Glycoproteins Industry Value Chain
10.2 Bio-Therapeutic Glycoproteins Upstream Market
10.3 Bio-Therapeutic Glycoproteins Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Bio-Therapeutic Glycoproteins Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Key Players of Bio-Therapeutic Glycoproteins in Global Market
Table 2. Top Bio-Therapeutic Glycoproteins Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Bio-Therapeutic Glycoproteins Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Bio-Therapeutic Glycoproteins Revenue Share by Companies, 2018-2023
Table 5. Global Bio-Therapeutic Glycoproteins Sales by Companies, (K Units), 2018-2023
Table 6. Global Bio-Therapeutic Glycoproteins Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Bio-Therapeutic Glycoproteins Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Bio-Therapeutic Glycoproteins Product Type
Table 9. List of Global Tier 1 Bio-Therapeutic Glycoproteins Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bio-Therapeutic Glycoproteins Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Bio-Therapeutic Glycoproteins Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Bio-Therapeutic Glycoproteins Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Bio-Therapeutic Glycoproteins Sales (K Units), 2018-2023
Table 15. By Type - Global Bio-Therapeutic Glycoproteins Sales (K Units), 2024-2029
Table 16. By Application ? Global Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Bio-Therapeutic Glycoproteins Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Bio-Therapeutic Glycoproteins Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Bio-Therapeutic Glycoproteins Sales (K Units), 2018-2023
Table 20. By Application - Global Bio-Therapeutic Glycoproteins Sales (K Units), 2024-2029
Table 21. By Region ? Global Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Bio-Therapeutic Glycoproteins Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Bio-Therapeutic Glycoproteins Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Bio-Therapeutic Glycoproteins Sales (K Units), 2018-2023
Table 25. By Region - Global Bio-Therapeutic Glycoproteins Sales (K Units), 2024-2029
Table 26. By Country - North America Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Bio-Therapeutic Glycoproteins Sales, (K Units), 2018-2023
Table 29. By Country - North America Bio-Therapeutic Glycoproteins Sales, (K Units), 2024-2029
Table 30. By Country - Europe Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Bio-Therapeutic Glycoproteins Sales, (K Units), 2018-2023
Table 33. By Country - Europe Bio-Therapeutic Glycoproteins Sales, (K Units), 2024-2029
Table 34. By Region - Asia Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Bio-Therapeutic Glycoproteins Sales, (K Units), 2018-2023
Table 37. By Region - Asia Bio-Therapeutic Glycoproteins Sales, (K Units), 2024-2029
Table 38. By Country - South America Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Bio-Therapeutic Glycoproteins Sales, (K Units), 2018-2023
Table 41. By Country - South America Bio-Therapeutic Glycoproteins Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Bio-Therapeutic Glycoproteins Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Bio-Therapeutic Glycoproteins Sales, (K Units), 2024-2029
Table 46. Genentech Company Summary
Table 47. Genentech Bio-Therapeutic Glycoproteins Product Offerings
Table 48. Genentech Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Genentech Key News & Latest Developments
Table 50. Hoffmann-La Roche Company Summary
Table 51. Hoffmann-La Roche Bio-Therapeutic Glycoproteins Product Offerings
Table 52. Hoffmann-La Roche Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Hoffmann-La Roche Key News & Latest Developments
Table 54. Genzyme Corp Company Summary
Table 55. Genzyme Corp Bio-Therapeutic Glycoproteins Product Offerings
Table 56. Genzyme Corp Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Genzyme Corp Key News & Latest Developments
Table 58. Abbott Laboratories Company Summary
Table 59. Abbott Laboratories Bio-Therapeutic Glycoproteins Product Offerings
Table 60. Abbott Laboratories Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Abbott Laboratories Key News & Latest Developments
Table 62. Amgen Company Summary
Table 63. Amgen Bio-Therapeutic Glycoproteins Product Offerings
Table 64. Amgen Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Amgen Key News & Latest Developments
Table 66. Biogen Company Summary
Table 67. Biogen Bio-Therapeutic Glycoproteins Product Offerings
Table 68. Biogen Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Biogen Key News & Latest Developments
Table 70. Merck Company Summary
Table 71. Merck Bio-Therapeutic Glycoproteins Product Offerings
Table 72. Merck Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Merck Key News & Latest Developments
Table 74. GlaxoSmithKline Company Summary
Table 75. GlaxoSmithKline Bio-Therapeutic Glycoproteins Product Offerings
Table 76. GlaxoSmithKline Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. GlaxoSmithKline Key News & Latest Developments
Table 78. Novartis Pharmaceuticals Corp Company Summary
Table 79. Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Product Offerings
Table 80. Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Novartis Pharmaceuticals Corp Key News & Latest Developments
Table 82. Bio-Therapeutic Glycoproteins Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Bio-Therapeutic Glycoproteins Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Bio-Therapeutic Glycoproteins Production by Region, 2018-2023 (K Units)
Table 85. Global Bio-Therapeutic Glycoproteins Production by Region, 2024-2029 (K Units)
Table 86. Bio-Therapeutic Glycoproteins Market Opportunities & Trends in Global Market
Table 87. Bio-Therapeutic Glycoproteins Market Drivers in Global Market
Table 88. Bio-Therapeutic Glycoproteins Market Restraints in Global Market
Table 89. Bio-Therapeutic Glycoproteins Raw Materials
Table 90. Bio-Therapeutic Glycoproteins Raw Materials Suppliers in Global Market
Table 91. Typical Bio-Therapeutic Glycoproteins Downstream
Table 92. Bio-Therapeutic Glycoproteins Downstream Clients in Global Market
Table 93. Bio-Therapeutic Glycoproteins Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Bio-Therapeutic Glycoproteins Segment by Type in 2022
Figure 2. Bio-Therapeutic Glycoproteins Segment by Application in 2022
Figure 3. Global Bio-Therapeutic Glycoproteins Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Bio-Therapeutic Glycoproteins Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Bio-Therapeutic Glycoproteins Revenue, 2018-2029 (US$, Mn)
Figure 7. Bio-Therapeutic Glycoproteins Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Bio-Therapeutic Glycoproteins Revenue in 2022
Figure 9. By Type - Global Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Bio-Therapeutic Glycoproteins Revenue Market Share, 2018-2029
Figure 11. By Type - Global Bio-Therapeutic Glycoproteins Sales Market Share, 2018-2029
Figure 12. By Type - Global Bio-Therapeutic Glycoproteins Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Bio-Therapeutic Glycoproteins Revenue Market Share, 2018-2029
Figure 15. By Application - Global Bio-Therapeutic Glycoproteins Sales Market Share, 2018-2029
Figure 16. By Application - Global Bio-Therapeutic Glycoproteins Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Bio-Therapeutic Glycoproteins Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Bio-Therapeutic Glycoproteins Revenue Market Share, 2018-2029
Figure 20. By Region - Global Bio-Therapeutic Glycoproteins Sales Market Share, 2018-2029
Figure 21. By Country - North America Bio-Therapeutic Glycoproteins Revenue Market Share, 2018-2029
Figure 22. By Country - North America Bio-Therapeutic Glycoproteins Sales Market Share, 2018-2029
Figure 23. US Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Bio-Therapeutic Glycoproteins Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Bio-Therapeutic Glycoproteins Sales Market Share, 2018-2029
Figure 28. Germany Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 29. France Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Bio-Therapeutic Glycoproteins Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Bio-Therapeutic Glycoproteins Sales Market Share, 2018-2029
Figure 37. China Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 41. India Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Bio-Therapeutic Glycoproteins Revenue Market Share, 2018-2029
Figure 43. By Country - South America Bio-Therapeutic Glycoproteins Sales Market Share, 2018-2029
Figure 44. Brazil Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Bio-Therapeutic Glycoproteins Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Bio-Therapeutic Glycoproteins Sales Market Share, 2018-2029
Figure 48. Turkey Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Bio-Therapeutic Glycoproteins Revenue, (US$, Mn), 2018-2029
Figure 52. Global Bio-Therapeutic Glycoproteins Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Bio-Therapeutic Glycoproteins by Region, 2022 VS 2029
Figure 54. Bio-Therapeutic Glycoproteins Industry Value Chain
Figure 55. Marketing Channels

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount